Standardized two-step testing of antibody activity in COVID-19 convalescent plasma
Summary: The COVID-19 pandemic revealed an urgent need for rapid profiling of neutralizing antibody responses and development of antibody therapeutics. The current Food and Drug Administration-approved serological tests do not measure antibody-mediated viral neutralization, and there is a need for s...
Main Authors: | Pavlo Gilchuk, Isaac Thomsen, Sandra Yoder, Eric Brady, James D. Chappell, Laura J. Stevens, Mark R. Denison, Rachel E. Sutton, Rita E. Chen, Laura A. VanBlargan, Naveenchandra Suryadevara, Seth J. Zost, Jonathan Schmitz, Jill M. Pulley, Michael S. Diamond, Jillian P. Rhoads, Gordon R. Bernard, Wesley H. Self, Todd W. Rice, Allison P. Wheeler, James E. Crowe, Jr., Robert H. Carnahan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004221015728 |
Similar Items
-
Real-time cell analysis: A high-throughput approach for testing SARS-CoV-2 antibody neutralization and escape
by: Naveenchandra Suryadevara, et al.
Published: (2022-06-01) -
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals
by: Elaine C. Chen, et al.
Published: (2021-08-01) -
An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer
by: Naveenchandra Suryadevara, et al.
Published: (2022-06-01) -
A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis.
by: Leslie Goo, et al.
Published: (2017-02-01) -
Structural Biology Illuminates Molecular Determinants of Broad Ebolavirus Neutralization by Human Antibodies for Pan-Ebolavirus Therapeutic Development
by: Charles D. Murin, et al.
Published: (2022-01-01)